phrykt

Vertex Pharmaceuticals Inc / Ma (VRTX) cash: $5.1B

Vertex Pharmaceuticals Inc / Ma held $5.1B in cash and cash equivalents on Dec 31, 2025, up 11.3% from $4.6B a year earlier.

From Vertex Pharmaceuticals Inc / Ma's filings with the SEC · Read the filing · VRTX stock page

Vertex Pharmaceuticals Inc / Ma cash by year

$6.8B2021$10.5B2022$10.4B2023$4.6B2024$5.1B2025

#124 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$5.1B+11%
Dec 31, 2024$4.6B-56%
Dec 31, 2023$10.4B-1%
Dec 31, 2022$10.5B+55%
Dec 31, 2021$6.8B–

Cash of similar companies

Companies in the same industry as Vertex Pharmaceuticals Inc / Ma, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Abbott Laboratories$8.5BDec 31, 2025
Eli Lilly$7.3BDec 31, 2025
AbbVie$5.2BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$5.1BDec 31, 2025
BeOne Medicines$4.5BDec 31, 2025
TEVA Pharmaceutical Industries$3.6BDec 31, 2025
Regeneron Pharmaceuticals$3.1BDec 31, 2025

Questions and answers

What is Vertex Pharmaceuticals Inc / Ma's cash?

Vertex Pharmaceuticals Inc / Ma held $5.1B in cash and cash equivalents on Dec 31, 2025, up 11.3% from $4.6B a year earlier.

Numbers as reported in Vertex Pharmaceuticals Inc / Ma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology